How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any additional equality or health inequalities issues we should consider?

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

Guidance assessment consultation document for HTE10065 Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

2 Information about the technologies

2.1

The 5 technologies included in this early-use assessment apply artificial intelligence (AI)-derived algorithms or rules-based algorithms to spirometry to support the diagnosis of lung conditions (see tTable 1). The technologies provide support by:

  • quality assessing spirometry performance

  • interpreting spirometry results (for example, recognising whether the spirometry trace is obstructive, restrictive or otherwise)

  • suggesting a diagnosis based on spirometry results and other clinical factors.

2.2

Four of the included technologies (ArtiQ.Spiro, EasyOne Connect, LungHealth and MIR Spiro) are software only, but do require spirometry hardware to complete testing. One technology (Go Spiro) includes both hardware (such as a spirometer) and software elements. The technologies can be used in primary care and community diagnostic centres alongside a healthcare professional.

2.3

NuvoAir is no longer available to the NHS, so the committee could not make a recommendation on this technology.

Table 1 Technologies included in the assessment

Technology (company) 

CE mark 

Population 

Type of algorithm 

Setting 

Component parts 

ArtiQ.Spiro [ArtiQ.PFT] 
(Clario) 

IIa 

5 to 96 years for quality assessment and pattern recognition, 18 years and over for providing a diagnostic suggestion

AI and rules-based (uses ATS and ERS guidelines) 

Clinic 

Software that is compatible with specified spirometers

LungHealth (LungHealth) 

I 

18 years and over for COPD, 12 years and over for asthma 

AI and rules-based (uses BTS, GOLD, NICE and SIGN guidelines) 

Clinic 

Software that requires input of spirometry results (performed using any spirometry hardware)

MIR Spiro (Medical International Research – MIR) 

IIa 

5 years and over  

Rules-based (uses ATS and ERS guidelines) 

Clinic 

Software that is compatible with specified spirometers

EasyOne Connect (NDD) 

IIa 

4 years and over 

Rules-based (uses ATS and ERS guidelines) 

Clinic 

Software that is compatible with specified spirometers

GoSpiro (Monitored Therapeutics)

IIa 

5 years and over

AI and rules-based (uses ATS and ERS guidelines) 

Clinic 

Software and hardware (such as spirometer) components

NuvoAir (NuvoAir) 

[Air Next] 

IIa 

5 years and over

AI (interpretation of spirometry results) and rules-based (ATS 2019) 

Home based 

Software and hardware (such as spirometer) components provided

Abbreviations: ,; BTS, British Thoracic Society; ERS,; GOLD, ; IGN, .

Sustainability

2.4

None of the companies with technologies included in this assessment disclosed their Carbon Reduction Plans for UK carbon emissions.